Robert B. Warner

Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues:  Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation

Le Wang, Keith W. Woods, Qun Li et al. · Journal of Medicinal Chemistry · 2002 · 421 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737

Stephen K. Tahir, Xiufen Yang, Mark G. Anderson et al. · Cancer Research · 2007 · 302 citations

Medicine, Oncology, Pharmacology +13

A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs <i>In vitro</i> and <i>In vivo</i>

Alex R. Shoemaker, Anatol Oleksijew, Joy Bauch et al. · Cancer Research · 2006 · 146 citations

Medicine, Oncology, Pharmacology +10

Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent

Qun Li, Keith W. Woods, Akiyo Claiborne et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 124 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Novel sulfonate analogues of combretastatin A-4

Stephen L. Gwaltney, Hovis Imade, Kenneth J. Barr et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8